Status:
COMPLETED
RCT of Effects of Device-guided Breathing on Ambulatory BP
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Hypertension
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Our aim is to conduct a randomized controlled trial (RCT) to test the efficacy of a guided breathing intervention on ambulatory blood pressure (ABP), both systolic and diastolic BP. There are 3 groups...
Detailed Description
Device-guided breathing is a behavioral intervention that guides the breathing into the 6 per minute range, inducing respiratory sinus arrythmia (RSA), which is the natural cycle of arrythmia that occ...
Eligibility Criteria
Inclusion
- Diagnosis of Hypertension
- Treated with at least one antihypertensive drug
- BP still not controlled (\>135/85 on Ambulatory BP waking average)
Exclusion
- Diabetes
- Atrial Fibrillation
- Pregnancy
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
253 Patients enrolled
Trial Details
Trial ID
NCT01184755
Start Date
May 1 2008
End Date
July 1 2014
Last Update
May 16 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UMDNJ - Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States, 08901
2
Columbia University Medical Center
New York, New York, United States, 10032